AzTrials
AzTrials

Adolescent Idiopathic ScoliosisNCT02590380

Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity

A study testing MESA Rail Deformity System and DePuy Synthes USS II System in people with Adolescent Idiopathic Scoliosis, run by K2M, Inc. at 1 site in United Kingdom.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. Read more about this study

Who is it for?
Ages 11 to 21 years
Conditions the study is for
Adolescent Idiopathic Scoliosis
What is being tested?
MESA Rail Deformity System and DePuy Synthes USS II System
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited Kingdom
Study dates
Sep 2022to Sep 2030
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Diagnosis of Adolescent Idiopathic Scoliosis (AIS) with no associated syndrome requiring surgical treatment for selective thoracic/lumbar fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies. AIS cases must be classified as a Lenke type 1 or type 2 curve. No cervical vertebrae are to be incorporated into the construct.
  • Willingness and ability to comply with the requirements of the protocol including follow-up requirements.
  • Willing and able to sign a study specific informed consent form or, in the case of a patient who is a minor, provide assent and the minor patient's parent/legal guardian provides written consent to participate.
  • Age range of ≥ 11 years old and ≤ 21 years old at time of surgery.

Who cannot join

  • Previous anterior or posterior spine surgery at the index levels.
  • Previous posterior spine surgery (e.g., posterior element decompression) that destabilizes the cervical/thoracic/lumbar spine.
  • Active systemic infection or infection at the operative site.
  • Any sign of any spinal dysrhaphism (any cord abnormality).
  • Co-morbid medical conditions of the spine or upper/lower extremities that may affect the thoracic or lumbar spine neurological and/or pain assessment.
  • Metabolic bone disease such as osteoporosis that contradicts spinal surgery.
Show all 18Show fewer
  • History of an osteoporotic fracture.
  • History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism.
  • Taking medications that may interfere with bony/soft tissue healing including chronic oral steroid use.
  • Known allergy to titanium or cobalt chrome.
  • Rheumatoid arthritis or other autoimmune disease or a systemic disorder such as HIV, active hepatitis B or C or fibromyalgia.
  • Insulin-dependent type 1 or type 2 diabetes.
  • Medical condition (e.g., unstable cardiac disease, cancer) that may result in patient death or have an effect on outcomes prior to study completion.
  • Pregnant, or intend to become pregnant, during the course of the study.
  • Severe obesity (Body Mass Index > 40).
  • Physical or mental condition (e.g., psychiatric disorder, senile dementia, Alzheimer's disease, alcohol or drug addiction) that would interfere with patient self-assessment of function, pain or quality of life.
  • Incarcerated at the time of study enrollment.
  • Current participation in an investigational study that may impact study outcomes.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospital Southampton

    Southampton, S)16 6YD

Other trials in United Kingdom

About this study

Official title: A Randomized Controlled Trial: Comparison of a Top Loading MESA® Spinal System With MESA Rail™ and a Side Locking Pedicle Screw System for the Treatment of Adolescent Paediatric Spine Deformity

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system.

Read the detailed description

Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. This is a single-center, single-surgeon randomized controlled trial with follow-up evaluations of patients conducted at initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure. Adverse events will be monitored continuously.

Being tested
MESA Rail Deformity System, DePuy Synthes USS II System
Keywords
Adolescent, paediatric, pediatric, scoliosis, spine deformity
Medical subject headings
Scoliosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MESA Rail Deformity SystemDevice

    Also called MESA Rail, K2M MESA Rail, MESA, K2M MESA

    The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the MESA Rail Deformity System.

  • DePuy Synthes USS II SystemDevice

    Also called DePuy, DePuy Synthes, Synthes, USS II, Universal Stainless

    The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the DePuy Synthes USS II system.

Study groups in NCT02590380
Study groupRoleWhat they receive
treatment group (MESA)Active comparatorPatients randomized to the treatment group will receive surgery with the MESA Rail Deformity System.
Receives: Device: MESA Rail Deformity System
control group (USS II)Active comparatorPatients randomized to the control group will receive surgery with the DePuy Synthes USS II System.
Receives: Device: DePuy Synthes USS II System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correction and Maintenance of Spinal Deformity (coronal)

    Radiographic analysis of the spinal deformity in the coronal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.

    Measured: Change from pre-operative to 3 months, 12 months and 24 months post-procedure

  2. Correction and Maintenance of Spinal Deformity (sagittal)

    Radiographic analysis of the spinal deformity in the sagittal plane at the indicated time periods will be compared to the pre-operative measurements (OVERALL CHANGE from baseline at each timepoint). Later post-operative measurements will be compared to the initial correction values to establish maintenance of surgical correction over time.

    Measured: Change from pre-operative to 3 months, 12 months and 24 months post-procedure

Secondary outcomes (7)
  1. Back and Leg Pain 10cm Visual Analog Scale (VAS)

    The severity of back and leg pain will be evaluated in all study subjects using a 10-cm visual analog scale (VAS). The study will employ a 15% improvement for success. OVERALL CHANGE from baseline will be assessed at each timepoint.

    Measured: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  2. SRS-22

    Scoliosis and its treatment have a great impact on the quality of life of the affected patients. The Revised Scoliosis Research Society-22 (SRS-22r) is a specific questionnaire for spine conditions. It is applied to patients with idiopathic scoliosis, whose conditions and treatments have a great impact on their quality of life. The SRS-22r was created and revised with the purpose of evaluating this impact from the patient's point of view. The reviewed version contains 22 questions distributed into five domains: function/activity (FA), pain (P), self-image/appearance (SA), mental health (MH) and satisfaction with treatment (ST). The scores vary from 1 to 5, in which 5 is the best health quality of life of patients. OVERALL CHANGE from baseline will be assessed at each timepoint.

    Measured: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  3. Estimated Blood Volume Loss/Salvage Return

    The amount of blood loss over the entire length of the surgery as well as salvage return volumes will be captured intraoperatively.

    Measured: Operative Data - to be collected immediately after case is completed. Estimated blood loss will be noted by the surgical/anesthesia team and this value can then be immediately collected.

  4. Length of Hospital Stay

    The length of hospital stay from the date of admission to the date of discharge will be calculated.

    Measured: At discharge (up to one week post surgery) - Once the subject has been released from the hospital, the length of hospital stay can be calculated using the intake and discharge dates.

  5. Return to Work/School

    The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery will be documented. Once the subject has returned to the "baseline" status this question will not be asked.

    Measured: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  6. Return to Sport/Physical Activity

    The ability to return to sport as performed by the individual patient pre operatively. Time to walking unaided, running, swimming, trampoline, contact sport, normal social interactions with peer group. Once the subject has returned to the "baseline" status this question will not be asked.

    Measured: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

  7. Use of Analgesia Post-Surgery

    The types and dosages of any analgesia taken by the patient post-surgery will be documented. Overall change from baseline (pre-operative medications) will be analyzed at each interval - anticipation is that use of analgesia decreases and/or ends after surgery.

    Measured: Initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2015 (estimated)
  2. Study startSep 2022 (estimated)
  3. Primary completionSep 2028 (estimated)
  4. Study completionSep 2030 (estimated)

Why it stopped: Study was not started

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02590380
Sponsor's protocol ID
CAS-029
Status last verified
Oct 2021
First submitted
22 Oct 2015
Last updated
21 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing MESA Rail Deformity System and DePuy Synthes USS II System in people with Adolescent Idiopathic Scoliosis, run by K2M, Inc. at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 21 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correction and Maintenance of Spinal Deformity (coronal) (time frame: Change from pre-operative to 3 months, 12 months and 24 months post-procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in